Digital Making behaviour change stick Behaviour change is set to become a key skill for pharma companies in the very near future – an essential beyond-the-pill strategy, often delivered via digital tech, that can help keep peop
News Regeneron swoops on genetic testing firm 23andMe DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.